These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21166538)

  • 21. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccines and immunization against human papillomavirus.
    Christensen ND; Budgeon LR
    Curr Probl Dermatol; 2014; 45():252-64. PubMed ID: 24643192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccines--immune responses.
    Stanley M; Pinto LA; Trimble C
    Vaccine; 2012 Nov; 30 Suppl 5():F83-7. PubMed ID: 23199968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: immunological problems and future directions.
    Chen J; Ni G; Liu XS
    Cell Immunol; 2011; 269(1):5-9. PubMed ID: 21477796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects and prejudices of human papillomavirus vaccines in India.
    Das BC; Hussain S; Nasare V; Bharadwaj M
    Vaccine; 2008 May; 26(22):2669-79. PubMed ID: 18455843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines for preventing HPV-related anogenital infection and neoplasia.
    Ferris DG
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus vaccines.
    Stanley MA
    Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.
    Stanley M; Gissmann L; Nardelli-Haefliger D
    Vaccine; 2008 Aug; 26 Suppl 10():K62-7. PubMed ID: 18847558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
    Shaw AR
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV vaccines.
    Stanley M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the impact of human papillomavirus vaccines.
    Chang Y; Brewer NT; Rinas AC; Schmitt K; Smith JS
    Vaccine; 2009 Jul; 27(32):4355-62. PubMed ID: 19515467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
    Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
    Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer prevention & the role of human papillomavirus vaccines in India.
    Bhatla N; Joseph E
    Indian J Med Res; 2009 Sep; 130(3):334-40. PubMed ID: 19901443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.